RZLT ▼ -1.2% - Rezolute, Inc.
$RZLT - Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
05-OCT-2026 07:00 AM ET
Share this post
More filings for $RZLT
RZLT ▼ -1.7% - Rezolute, Inc.Sep 24, 2026RZLT ▼ -3.0% - Rezolute, Inc.Sep 9, 2026RZLT ▼ -1.6% - Rezolute, Inc.Sep 2, 2026RZLT - Rezolute, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026RZLT - Rezolute, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026RZLT - Rezolute, Inc. - SEC Filing Update (12-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 12, 2026
View full $RZLT filing history →💬 Comments
Loading comments…
Leave a comment